NIH Funding Opportunities (Notices, PA, RFA)

Syndicate content
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 6 hours 29 min ago

Notice of NICHD Participation in PAR-18-205 "NIBIB Biomedical Technology Resource Centers (P41 - Clinical Trial Optional)"

December 8, 2017 - 1:59pm
Notice NOT-HD-17-030 from the NIH Guide for Grants and Contracts
Categories: NIH

Notice of NIA Participation in PAR-16-355 "Social Epigenomics Research Focused on Minority Health and Health Disparities (R01)"

December 8, 2017 - 1:51pm
Notice NOT-AG-17-025 from the NIH Guide for Grants and Contracts
Categories: NIH

Notice of NIA Participation in PAR-16-356 "Social Epigenomics Research Focused on Minority Health and Health Disparities (R21)"

December 8, 2017 - 11:18am
Notice NOT-AG-17-026 from the NIH Guide for Grants and Contracts
Categories: NIH

The Role of Stem/Progenitor Cells in the Pathogenesis and Treatment of Gynecologic Disorders (R01 - Clinical Trial Optional)

December 8, 2017 - 3:49am
Funding Opportunity RFA-HD-19-013 from the NIH Guide for Grants and Contracts. The purpose of the Funding Opportunity Announcement (FOA) is to encourage research into the role of pluripotent progenitor/stem cells in the pathogenesis and treatment of selected gynecologic disorders, specifically uterine fibroids, endometriosis, adenomyosis, endometrial polyps, and pelvic organ prolapse.
Categories: NIH

Promoting Research in Basic Neuroscience (R01)

December 8, 2017 - 3:22am
Funding Opportunity PAS-18-483 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to stimulate research addressing fundamental questions in basic neuroscience. Proposed projects can address any area of neuroscience within the missions of the participating institutes and should focus on understanding the development, the structure and/or the function of the normal nervous system. While fundamental basic research often generates insights relevant to disorders of the nervous system, this FOA is not intended to stimulate research that is explicitly disease-related.
Categories: NIH

Notice of Expiration of PAR-15-289 "The Pancreatic Cancer Detection Consortium (U01)"

December 8, 2017 - 2:39am
Notice NOT-CA-18-029 from the NIH Guide for Grants and Contracts
Categories: NIH

Notice of NINDS' Participation in PA-18-NNN "NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)"

December 8, 2017 - 2:24am
Notice NOT-NS-18-026 from the NIH Guide for Grants and Contracts
Categories: NIH

Notice of NIAMS' Participation in PA-18-369 "Mentored Research Scientist Development Award (Parent K01 -Independent Clinical Trial Not Allowed)

December 8, 2017 - 2:17am
Notice NOT-AR-18-009 from the NIH Guide for Grants and Contracts
Categories: NIH

NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trials Not Allowed)

December 7, 2017 - 1:56pm
Funding Opportunity RFA-EY-17-003 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to stimulate development of translation-enabling models for evaluating survival and integration of regenerated photoreceptors (PRCs) and retinal ganglion cells (RGCs) in model systems that are closer to human visual anatomy, function and/or disease than current models. The development of these models, tools, devices, novel therapies and/or other resources is expected to provide a resource to vision researchers developing cell-replacement therapies for visual system diseases and disorders. This FOA seeks to develop models that emulate critical aspects of a human blinding disease that might be amenable to regenerative therapy. The model system might involve specific defects generated by transgenic gene insertion and/or deletion, gene editing, chemical/physical means, and/or other approaches to emulate characteristics of human disease or create defects amenable to cell-replacement therapy. Model systems using non-human primates or other cone-dominant species that are more representative of the anatomy and physiology of the human retina are highly encouraged. Other biological models are acceptable provided they meet the overall objectives of the FOA. An important aspect of this FOA is that the research team is expected to treat the loss of vision associated with the experimental model using an approach that involves regenerating PRCs and/or RGCs and their connections. The choice of cells for therapy might include adult stem cells, precursors, stem cell derived progenitor cells, or conversion of intrinsic cells such as glia. It is expected that quantitative measures will be used to evaluate survival and integration of the regenerated cells using electrophysiology, functional imaging, behavioral measures or any other appropriate technology that would demonstrate circuit integration and restoration of visual function.
Categories: NIH

Notice of Intent to Publish a Funding Opportunity Announcement for National Research Mentoring Network Resource Center (U24 - Clinical Trial Not Allowed)

December 7, 2017 - 1:22pm
Notice NOT-RM-18-004 from the NIH Guide for Grants and Contracts
Categories: NIH

Prevention and Treatment Research to Address HIV/AIDS Disparities in Women in the US (R01-Accepting applications that either propose or do not propose clinical trial(s))

December 7, 2017 - 12:08pm
Funding Opportunity RFA-MD-18-004 from the NIH Guide for Grants and Contracts. This initiative will support health services, intervention, and implementation research to understand and reduce racial/ethnic, geographic, and socioeconomic HIV disparities in US women. Projects may address HIV prevention, screening and diagnosis, and/or treatment. Projects may involve primary data collection and/or secondary analysis of existing data.
Categories: NIH

Detecting and Preventing Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R01- Clinical Trial Required)

December 7, 2017 - 12:05pm
Funding Opportunity PAR-18-479 from the NIH Guide for Grants and Contracts. This initiative supports research to test the effectiveness of combined strategies to both detect and intervene to reduce the risk of suicide behavior, suicide ideation, and non-suicidal self-harm (NSSI) by youth in contact with the juvenile justice system. Opportunities for detection and prevention start at early points of contact (e.g., police interaction, the intake interview) and continue through many juvenile justice settings (e.g., pre-trial detention, juvenile or family court activities, court disposition, placement and on-going care in either residential or multiple community settings.) This FOA invites intervention strategies that are designed to be delivered in typical service settings using typically available personnel and resources, to enhance the implementation of interventions that prove effective, enhance their future uptake in diverse settings, and thereby reduce risk of suicide and self-harm in this population. This FOA is published in parallel to a companion R34 FOA (PAR-xx-xxx) supporting pilot studies in preparation for the larger-scale studies described here.
Categories: NIH

Notice of Correction for PAR-18-464 Clinical and Translational Science Award (U54 Clinical Trial Optional)

December 7, 2017 - 11:20am
Notice NOT-TR-18-012 from the NIH Guide for Grants and Contracts
Categories: NIH

Notice of Correction to Funding Opportunity Description for RFA-HL-16-025 "NHLBI Emerging Investigator Award (EIA) (R35)"

December 7, 2017 - 11:08am
Notice NOT-HL-17-569 from the NIH Guide for Grants and Contracts
Categories: NIH